MedPath

The effect of probiotics in the treatment of urinary tract infections in children 6 months to 12 years

Phase 3
Recruiting
Conditions
rinary tract infection.
Urinary tract infection, site not specified
N39.0
Registration Number
IRCT20211028052897N1
Lead Sponsor
Zanjan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
48
Inclusion Criteria

All patients 6 months to 12 years with diagnosis of urinary tract infection (urine analysis and positive urine culture)
Lack of allergy of the patient to probiotic drug (pedilact)
Willingness to participate in the study

Exclusion Criteria

Renal anomalies
Having any type of immunodeficiency
Having a UTI and another infectious disease at the same time
Emphysematous pyelonephritis
Allergy to probiotic drug (pedilact) or intolerance to it

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improve the symptoms of urinary tract infection. Timepoint: 2 and 5 days after starting Probiotic treatment (pedilact). Method of measurement: Urine culture.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath